You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

New Drug Combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Disease Trial in Milano (DES+DCB)

Enrolling by invitation
  • Coronary Artery Disease
  • DES+DCB
  • Milano, Italy
    Istituto Clinico S.Ambrogio
Dec 4, 2022

Non-healing Wound, Non-Healing Ulcer of Skin Trial in Santa Fe (Omeza Products Used in Combination)

Recruiting
  • Non-healing Wound
  • Non-Healing Ulcer of Skin
  • Omeza Products Used in Combination
  • Santa Fe, New Mexico
    Christus St. Vincent
Jun 19, 2023

Opioid-use Disorder Trial in New York (Buprenorphine/naloxone, Placebo)

Recruiting
  • Opioid-use Disorder
  • New York, New York
    Stars/Nyspi
Aug 11, 2022

Type2Diabetes, ASCVD Trial (SGLT2 inhibitor, GLP-1 receptor agonist, Combination drug)

Recruiting
  • Type2Diabetes
  • ASCVD
  • SGLT2 inhibitor
  • +2 more
  • New York, New York
  • +1 more
Dec 19, 2022

Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)

Not yet recruiting
  • Advanced Solid Tumors
  • LCB84
  • Anti-PD-1 monoclonal antibody
  • Los Angeles, California
  • +6 more
Jul 4, 2023

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Birmingham, Alabama
  • +25 more
Dec 9, 2022

Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • Palo Alto, California
  • +15 more
Jan 6, 2023

Opioid Use Disorder Trial in New Haven (NYX-783, Placebo, Oxycodone)

Not yet recruiting
  • Opioid Use Disorder
  • New Haven, Connecticut
  • +1 more
Dec 2, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • New Brunswick, New Jersey
  • +2 more
Jun 28, 2022

Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in United States (AZD4635, Oleclumab, Durvalumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Denver, Colorado
  • +8 more
Jan 12, 2023

Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in Belgium, United States (Bapotulimab (BAY1905254),

Active, not recruiting
  • Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma
  • Bapotulimab (BAY1905254)
  • Bapotulimab (BAY1905254) + Pembrolizumab
  • Tucson, Arizona
  • +7 more
Jan 12, 2023

Multiple Myeloma Trial in Leicester (CC-92480, Tazemetostat, BMS-986158)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +9 more
Oct 24, 2022

Healthy Trial in Hackensack (SPD503, Concerta, SPD503 + Concerta)

Completed
Has Results
  • Healthy
  • Hackensack, New Jersey
    Advanced Biomedical Research, Inc.
Jun 10, 2021

Healthy Trial in Hackensack (SPD503, VYVANSE, SPD503 and VYVANSE)

Completed
Has Results
  • Healthy
  • Hackensack, New Jersey
    Advanced Biomedical Research, Inc.
Jun 10, 2021

Tumor Trial in Italy, New Zealand, United States (ipilimumab, nivolumab, ENHANZE (rHuPH20))

Active, not recruiting
  • Tumor
  • Hartford, Connecticut
  • +5 more
Nov 16, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Binge-Eating Disorder Trial in New Haven (Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination, Placebo)

Active, not recruiting
  • Binge-Eating Disorder
  • Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination
  • Placebo
  • New Haven, Connecticut
    Yale School of Medicine
Feb 18, 2022

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022

Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

Recruiting
  • Acute Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Atlanta, Georgia
  • +13 more
Jan 26, 2023

Leiomyosarcoma Trial in United States (TTI-621, Doxorubicin)

Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
  • +26 more
Jul 26, 2022

Coronary Artery Disease Trial in Italy (DES+DCB)

Unknown status
  • Coronary Artery Disease
  • DES+DCB
  • Rho, Milano, Italy
  • +5 more
Jan 15, 2021

Hyperkalemia Trial in United States (Patiromer Powder for Oral Suspension [Veltassa], Placebo)

Recruiting
  • Hyperkalemia
  • Patiromer Powder for Oral Suspension [Veltassa]
  • Placebo
  • Stanford, California
  • +14 more
May 25, 2022

Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +3 more
  • New York, New York
  • +4 more
Jul 16, 2022

Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

Recruiting
  • Mycosis Fungoides
  • +11 more
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +12 more
Jan 7, 2023

Tumors, NSCLC, Pancreatic Tumors Trial in Worldwide (V941, Pembrolizumab)

Completed
  • Neoplasms
  • +3 more
  • V941
  • Pembrolizumab
  • Gilbert, Arizona
  • +25 more
Sep 5, 2022